Pilocarpine - Orasis Pharmaceuticals
Alternative Names: CSF -1- low dose pilocarpine hydrochloride 0.4%; CSF-1 - Orasis Pharmaceuticals; Pilocarpine hydrochloride ophthalmic solution; PresbiDrops; PresbiDrops (CSF-1); QlosiLatest Information Update: 18 Aug 2025
At a glance
- Originator Orasis Pharmaceuticals
- Class Alkaloids; Antiglaucomas; Eye disorder therapies; Furans; Imidazoles; Ketones; Miotics; Small molecules
- Mechanism of Action Muscarinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Presbyopia